HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON’S DISEASE

INTRODUCTION: Homocysteine is process-product of methionine demethylation. It has proatherogenic, prothrombotic, prooxidative, proapoptotic, osteoporotic, neurotoxic, neuroinflamatory, and neurodegenerative effects. Hyperhomocysteinemia correlates with C667T MTHFR mutation, decrease of folic acid an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mater Sociomed
Autori principali: Ibrahimagic, Omer C., Smajlovic, Dzevdet, Dostovic, Zikrija, Pasic, Zejneba, Kunic, Suljo, Iljazovic, Amra, Hajdarevic, Denisa Salihovic
Natura: Artigo
Lingua:Inglês
Pubblicazione: AVICENA, d.o.o., Sarajevo 2016
Soggetti:
Original Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034996/
https://ncbi.nlm.nih.gov/pubmed/27698607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5455/msm.2016.28.303-306
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi